Style | Citing Format |
---|---|
MLA | Badrooj N, Jayedi A, Shabbidar S. "Ideal Cardiovascular Health Metrics and Risk of Type 2 Diabetes: A Systematic Review and Dose-Response Meta-Analysis of Prospective Cohort Studies." Nutrition# Metabolism and Cardiovascular Diseases, vol. 33, no. 11, 2023, pp. 2067-2075. |
APA | Badrooj N, Jayedi A, Shabbidar S (2023). Ideal Cardiovascular Health Metrics and Risk of Type 2 Diabetes: A Systematic Review and Dose-Response Meta-Analysis of Prospective Cohort Studies. Nutrition# Metabolism and Cardiovascular Diseases, 33(11), 2067-2075. |
Chicago | Badrooj N, Jayedi A, Shabbidar S. "Ideal Cardiovascular Health Metrics and Risk of Type 2 Diabetes: A Systematic Review and Dose-Response Meta-Analysis of Prospective Cohort Studies." Nutrition# Metabolism and Cardiovascular Diseases 33, no. 11 (2023): 2067-2075. |
Harvard | Badrooj N, Jayedi A, Shabbidar S (2023) 'Ideal Cardiovascular Health Metrics and Risk of Type 2 Diabetes: A Systematic Review and Dose-Response Meta-Analysis of Prospective Cohort Studies', Nutrition# Metabolism and Cardiovascular Diseases, 33(11), pp. 2067-2075. |
Vancouver | Badrooj N, Jayedi A, Shabbidar S. Ideal Cardiovascular Health Metrics and Risk of Type 2 Diabetes: A Systematic Review and Dose-Response Meta-Analysis of Prospective Cohort Studies. Nutrition# Metabolism and Cardiovascular Diseases. 2023;33(11):2067-2075. |
BibTex | @article{ author = {Badrooj N and Jayedi A and Shabbidar S}, title = {Ideal Cardiovascular Health Metrics and Risk of Type 2 Diabetes: A Systematic Review and Dose-Response Meta-Analysis of Prospective Cohort Studies}, journal = {Nutrition# Metabolism and Cardiovascular Diseases}, volume = {33}, number = {11}, pages = {2067-2075}, year = {2023} } |
RIS | TY - JOUR AU - Badrooj N AU - Jayedi A AU - Shabbidar S TI - Ideal Cardiovascular Health Metrics and Risk of Type 2 Diabetes: A Systematic Review and Dose-Response Meta-Analysis of Prospective Cohort Studies JO - Nutrition# Metabolism and Cardiovascular Diseases VL - 33 IS - 11 SP - 2067 EP - 2075 PY - 2023 ER - |